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Background: Extracorporeal membrane oxygenation (ECMO) technology is a viable option for short-term support
in the setting of acute cardiac ischemia. To supplement cardiopulmonary resuscitation (CPR) in select patients,
ECMO is used successfully for witnessed in hospital cardiac arrest. In the setting of an acute myocardial infarction
(MI), bridging to a revascularization procedure is important in improving overall survival.
Case presentation: We describe the first known case of a 56-year-old Caucasian male with an anterior ST elevation
myocardial infarction (STEMI) who underwent percutaneous coronary intervention (PCI) in which the entire procedure
was carried out with the patient being in persistent ventricular fibrillation (VF) resistant to defibrillation on ECMO
support. Subsequent to revascularization, the patient’s cardiac rhythm converted back to sinus rhythm with a
single defibrillation shock with excellent neurologic recovery.
Conclusion: Our case highlights the importance of early initiation of ECMO during PCI in achieving both
improved cardiac and neurological outcomes during an acute coronary syndrome (ACS).
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Extracorporeal membrane oxygenation (ECMO) technol-
ogy has advanced significantly and is readily available at
the bedside. This is a viable option for short-term support
in the setting of acute cardiac ischemia. According to
the 2003 USA National Registry of Cardiopulmonary
Resuscitation, in hospital cardiac arrest has a poor prog-
nosis with an overall survival to hospital discharge rate
of 17% with conventional cardiopulmonary resuscitation
(CPR) [1]. One of the most common causes of cardiac ar-
rest is ventricular fibrillation (VF) secondary to ischemia
which carries an improved prognosis if successfully defi-
brillated with survival to hospital discharge of 34% [1].
In cases with refractory ischemic VF, definitive therapy
with percutaneous coronary intervention (PCI) may not* Correspondence: aravandi@sbgh.mb.ca
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unless otherwise stated.be possible without anoxic brain injury secondary to
hemodynamic collapse.
Cardiopulmonary resuscitation was introduced in the
1960’s as a lifesaving method in patients with cardiac arrest
[2]. To supplement CPR in select patients, extracorporeal
membrane oxygenation (ECMO) is used successfully
for witnessed in hospital cardiac arrest [2]. In the set-
ting of an acute myocardial infarction (MI), bridging to a
revascularization procedure is important in improving
overall survival.
We describe the first known case of PCI in which the
entire procedure was carried out with the patient being
in persistent VF resistant to defibrillation on ECMO sup-
port. Subsequent to revascularization, the patient’s cardiac
rhythm converted back to sinus rhythm with a single de-
fibrillation shock with excellent neurologic recovery (cere-
bral performance category 1).
Case presentation
A 56-year-old Caucasian male with elevated lipids and
smoking history presented to a peripheral hospital with an
anterior ST elevation myocardial infarction. The patientLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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peripheral hospital emergency room for which he was
successfully defibrillated to normal sinus rhythm after
two attempts with 360 J. The total resuscitation period for
the first arrest was 15 minutes. Prior to dispatch to the
primary PCI center, the patient was started on parenteral
amiodarone with a loading dose of 150 mg followed by
50 mg/hr. En route to the tertiary care hospital with PCI
capabilities, the patient suffered a second cardiac arrest
with pulseless VT/VF. Immediate CPR was initiated by
the paramedics prior to arrival at the primary PCI centre.
In the ER, the patient required intubation and 40 minutes
of CPR with incessant VF refractory to defibrillation
and anti-arrhythmic therapy. Specifically, the patient
received a total of 4 mg of epinephrine and a total of
7 defibrillation shocks (360 J each). He also received
lidocaine 100 mg and amiodarone 150 mg loading
doses followed by infusions of both anti-arrhythmic
agents. He was started on lidocaine 2 mg/min and contin-
ued on the amiodarone 50 mg/hr intravenously. Due to
his young age and witnessed arrest, a decision was made
to initiate ECMO for hemodynamic support in the emer-
gency department. Peripheral veno-arterial ECMO access
was obtained using 17 size French (F) arterial cannula and
24/29 F venous cannula (Cook Medical, Bloomington,
IN). A Maquet Rotaflow centrifugal pump and a Quadrox
oxygenation system were used to complete the ECMO cir-
cuit (Masquet, Rastaat, Germany) as shown in Figure 1.
The patient was anti-coagulated with heparin during theFigure 1 Schematic diagram demonstrating the circuit for extracorpoECMO procedure aiming for a PTT of 59–99. The total
down time for the second cardiac arrest was 40 minutes
until the establishment of ECMO in the cath lab.
His initial laboratory investigations demonstrated se-
vere acidosis with a pH of 6.9, lactate of 10 mmol/L, and
elevated liver enzymes consistent with shock liver. On
ECMO support, the patient was taken for urgent cardiac
catheterization which confirmed a 90% thrombotic lesion
in the distal left main, 80% disease in the mid left anterior
descending artery (LAD), and 90% disease in the first ob-
tuse marginal (OM) with a dominant right coronary artery
free of any obstructive lesions (Figure 2A). A 3 mm×
8 mm Xience V (Abbott Vascular, Illinois, US) drug elut-
ing stent (DES) was used for the distal left main, 2.5 ×
15 mm Xience DES (Abbott Vacular, Illinois, US) for the
mid LAD, and a 2.5 × 38 mm Endeavor DES (Medtronic,
Minnesota, US) for the first OM with successful angio-
graphic results (Figure 2B). An attempt to completely
revascularize both culprit and non-culprit coronary le-
sions was performed as the patient was in cardiogenic
shock. The patient remained in refractory VF throughout
the entire PCI procedure (Figure 3A). Upon complete per-
cutaneous revascularization, a single defibrillation shock
restored the patient to normal sinus rhythm after 60 mi-
nutes of refractory VF (Figure 3B). The patient received
therapeutic hypothermia for neuro-protection in the in-
tensive care unit. After 48 hours post PCI, the patient was
taken off ECMO support. Although his initial transtho-
racic echocardiogram (TTE) revealed a left ventricularreal membrane oxygenation support used at our institution.
Figure 2 Coronary angiography prior to and post intervention: (A) Left coronary anatomy prior to percutaneous coronary intervention
demonstrating distal left main thrombus (arrow). (B) Patent left main post coronary intervention with a 3.0 × 8 mm drug eluting stent and
post dilated with a 3.5 × 8 non compliant balloon. The obtuse marginal also underwent angioplasty with 2.5 × 38 mm Endeavor drug eluting
stent (Medtronic, Minnesota, US) and post dilated with a 2.75 × 15 mm non-compliant balloon.
Figure 3 Intra operative monitor prior to and post intervention: (A) Incessant ventricular fibrillation on venous-arterial extracorporeal
membrane oxygenation support with a mean arterial pressure of 72 mmHg. (B) Post percutaneous coronary intervention demonstrating
return to normal sinus rhythm after successful defibrillation.
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kinesis, at day 9 post PCI, the LVEF improved to greater
than 50%. The creatinine kinase and high sensitivity tropo-
nin T peaked at 3251 U/L and 4130 ng/L, respectively.
The patient was discharged home 10 days later without
any neurologic deficits.
Discussion
Only recently has technology advanced enough to pro-
vide bedside mechanical cardiopulmonary support in an
emergency situation [3,4]. Published guidelines from the
Extracoporeal Life Support Organization indicate use of
ECMO in cases of reversible cardiac arrest or pulmonary
failure where conventional therapy has failed and the
mortality risk is considered to be greater than 50% [3,4].
In the case of veno-arterial ECMO, common indications
include cardiogenic shock post acute MI, post cardiac
surgery unable to wean off cardiopulmonary bypass,
myocarditis, bridge to transplant in end stage heart dis-
ease, or in the setting of early graft failure post heart
transplant [3,4].
There have been a number of studies evaluating the role
of ECMO in the setting of an acute coronary syndrome
(ACS) [2,4-6]. In a 3 year prospective observational study
of patients receiving greater than 10 minutes of CPR,
there was a higher survival rate to discharge and a better
1-year survival in patients treated with ECMO as com-
pared to conventional CPR [2]. In a retrospective study of
81 patients requiring ECMO for refractory cardiogenic
shock, Coombs et al. found that ECMO support could
rescue 40% of otherwise fatal refractory cardiogenic shock
with good quality of life outcome as measured by mental
and physical health [6]. In addition, use of ECMO in
combination with intra-arrest PCI was associated with
a higher survival rates in patients who were unresponsive
to conventional CPR [4-6]. This data supports the use of
ECMO in ACS refractory to conventional therapy where
there are no contraindications identified as a bridge to
complete revascularization.
Conclusion
Our case highlights the importance of early initiation of
ECMO during PCI in achieving both improved cardiac
and neurological outcomes during an ACS.
Consent
Written informed consent was obtained from the patient
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